Evidence Synthesis
Oxygenate Pharma Sees Strong Shift in Key Metrics, with Gross Margin Accelerating to 13.1% and Marginal Operating Leverage Improving to -0.19%.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 5 Sept 2026, 06:05
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
Oxygenate Pharma Sees Strong Shift in Key Metrics, with Gross Margin Accelerating to 13.1% and Marginal Operating Leverage Improving to -0.19%.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 13.1 % | -0.19 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -0.19 % | -10.04 | ▲ |
| REVENUE_GROWTH_YOY | 144.5 % | — | - |
| PRICE_CHANGE_PERCENT | -3.129 % | — | - |
| DAILY_VOLUME | 38,187 shares | 10,220 | ▲ |
| CLOSE_PRICE | 54.18 INR | 55.93 | ▼ |